⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for malignant glioma (who grade iii or iv)

Every month we try and update this database with for malignant glioma (who grade iii or iv) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent GliomaNCT01989052
Malignant Gliom...
CTO
Lomustine
18 Years - Duke University
Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab FailureNCT01954030
Malignant Gliom...
CTO and Bevaciz...
CTO alone
18 Years - Duke University
Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab FailureNCT01954030
Malignant Gliom...
CTO and Bevaciz...
CTO alone
18 Years - Duke University
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: